EVOQ Remedies Share Price
1.62+0.00 (+0.00%)
-55.86% past 1 Year
EVOQ Remedies Ltd. Limited specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. The company has a team of focused industry experts, who
Corporate filings & documents
Announcements
Corporate Insolvency Resolution Process (CIRP) - Admission of application by Tribunal
2 months agoCorporate Insolvency Resolution Process (CIRP) - Admission of application by Tribunal
2 months agoCorporate Insolvency Resolution process (CIRP) - Admission of application by Tribunal
2 months agoCorporate Insolvency Resolution process (CIRP) - Admission of application by Tribunal
2 months agoSubmission of Integrated Financial Results for the Half year and Year ended on 31st March 2026
3 months agoSubmission of Integrated Financial Results for the Half year and Year ended on 31st March 2026
3 months agoAppointment of Secretarial Auditor of the Company for FY 2025-26.
3 months agoAppointment of Secretarial Auditor of the Company for FY 2025-26.
3 months agoBoard of Directors has approved Audited Financials results for the Halh year and year ended on 31st March 2026
3 months agoBoard of Directors has approved Audited Financials results for the Halh year and year ended on 31st March 2026
3 months agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors in their meeting held today i.e. Saturday 30th May 2026 at the registered office of the Company which commenced at 04:00 P.M. and concluded at 07:15 P.M. inter alia has considered and approved: 1. Audited Financial Results for the Half Year and Year ended on 31st March 2026 along with Auditors Report. 2. Appointment of M/s. Jay Pandya & Associates (FRN: S2024GJ963300) Company Secretaries Ahmedabad as Secretarial Auditor of the Company for the Financial Year 2025-26.
3 months agoEvoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Companywhich was supposed to be held on Wednesday 27th May 2026 at 4:00 P.M. is now rescheduled to Saturday 30th May 2026 at 4:00 P.M. at the registered office of the Company situated at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 interalia to discuss and consider:1. The Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2026 along with Auditors Report.2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting.
3 months agoEvoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Companywhich was supposed to be held on Wednesday 27th May 2026 at 4:00 P.M. is now rescheduled to Saturday 30th May 2026 at 4:00 P.M. at the registered office of the Company situated at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 interalia to discuss and consider:1. The Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2026 along with Auditors Report.2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting.
3 months agoEvoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Thursday 14th May 2026 at 4:00 P.M. is now rescheduled to Wednesday 27th May 2026 at 4:00 P.M. at the registered office of the Company situated at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 interalia to discuss and consider:1. The Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2026 along with Auditors Report.2. Any other matter to be discussed and consider with the permission of Chairperson of theBoard Meeting
3 months agoEvoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements)Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company which was supposed to be held on Thursday 14th May 2026 at 4:00 P.M. is now rescheduled to Wednesday 27th May 2026 at 4:00 P.M. at the registered office of the Company situated at A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 interalia to discuss and consider:1. The Audited Financial Results of the Company for the Half Year and Year ended on 31st March 2026 along with Auditors Report.2. Any other matter to be discussed and consider with the permission of Chairperson of theBoard Meeting
3 months agoEvoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Thursday 14th May 2026
3 months agoEvoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Intimation of Board Meeting to be held on Thursday 14th May 2026
3 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Evoq Remedies Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L46209GJ2010PLC059692</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: NIKITA JAIN <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: YOGESH RAJPUT <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoCompliances- Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
4 months agoCompliances- Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
4 months agoIntimation of Closure of Trading Window
5 months agoSubmission of certificate of Reg74(5) of SEBI (Depositories and participants) Regulations 2018 for the Quarter ended on 31st December 2025
8 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhumishth Narendrabhai Patel
10 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bhumishth Narendrabhai Patel
10 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Payal Patel
10 months agoIntegrated Filling (Finance)
10 months agoFinancial Result fpr half year ended on 30th September 2025
10 months agoOutcome of Board Meeting hel today i.e. 10th October 2025
10 months agoCompliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations 2018
10 months agoEvoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2025 inter alia to consider and approve With reference to our earlier intimation dated 3rd October 2025 regarding the meeting of the Board of Directors of the Company scheduled to be held on today Thursday 9th October 2025 at 4:00 P.M. we wish to inform you that due to unavoidable circumstances the said meeting has been rescheduled to Friday 10th October 2025 at 4:00 P. M. at the registered office of the Company i.e. A-1106 Empire Business Hub Near AUDA Water Tank Science City Road Sola Ahmedabad - 380 060 inter alia to consider and approve:1. The Unaudited Financial Results of the Company for the Half Year ended on 30th September 2025 along with Limited Review Report.2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting.Kindly take the same on your record and oblige us.
11 months agoEvoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/10/2025 inter alia to consider and approve Intimation of Board Meeting to be held on Thursday 9th October 2025
11 months agoIntimation of the Closure of Trading Window
11 months agoVoting Results of the Annual General Meeting held on 17th September 2025
11 months agoScrutinizer Report of the Annual General Meeting of the Company held on 17th September 2025.
11 months agoOutcome and Summary of the Annual General Meeting held today i.e. 17th September 2025.
11 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
A-1106, Empire Business Hub Near Auda Water Tank Science City Road, Sola Ahmedabad Gujarat PIN: 380060 Tel No: NULL Fax No: NULL Email: [email protected] Internet: www.evoqremedies.com
Registrars
B1105-1108, K P Epitome, Nr. Makarba Lake, Nr. SiddhiVinayak Towers, Makarba, Ahmedabad – 380051 B1105-1108, K P Epitome Nr. Makarba Lake, Nr. Siddhi Vinayak Towers Makarba PIN: Tel No: NULL Fax No: NULL Email: [email protected] Internet: http://www.accuratesecurities.com/
Management
Bhumishth Patel, Managing Director
Narendrakumar Patel, Non Executive Director
Pushpa Joshi, Non Executive Independent Director
Harsh Kothari, Non Executive Independent Director
Nikita Jain, Company Secretary & Compliance Officer
Details
BSE 543500
NSE NULL
ISIN INE0JVD01011